Episode 15-24 High Tech Chasms and 23andMe
Jun 17, 2015•59 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
On this week’s Tech Nation, Moira speaks with GEOFF MOORE, Strategy Consultant
Author, “CROSSING THE CHASM: Marketing and Selling Disruptive Products to Mainstream Customers, third edition” about what happens to a hot tech companies that get a lot of interest early … and then never make it.
Then on BioTech Nation, ANNE WOJCICKI, the co-founder and CEO of 23andMe. From DNA analysis and a new grant from the National Institutes of Health to a new partnership with Pfizer on Crohn's Disease, there's more to 23andMe than meets the eye.
Author, “CROSSING THE CHASM: Marketing and Selling Disruptive Products to Mainstream Customers, third edition” about what happens to a hot tech companies that get a lot of interest early … and then never make it.
Then on BioTech Nation, ANNE WOJCICKI, the co-founder and CEO of 23andMe. From DNA analysis and a new grant from the National Institutes of Health to a new partnership with Pfizer on Crohn's Disease, there's more to 23andMe than meets the eye.
For the best experience, listen in Metacast app for iOS or Android